Allena Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy ALNA

*Your capital is at risk

$0.0270

+0 (+0%)

At Close: Feb 07, 2023

Currently predicting for Mon, 8 Jun 2026

ALNA Prediction Chart

ALNA Predictions History

Latest community submissions for ALNA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 1, 2021	$1.69 +1.20%	$1.67	X	98.80%	2
Sam196136	Feb 1, 2021	Bullish	$1.67	X	—	0
JS Pro	Apr 21, 2020	$1.68 -3.45%	$1.74	X	96.55%	1
تراحيب العتيبي @D8AAD8B1D8A7D8ADD98AD8A8D8A7D984D8B9D8AAD98AD8A8D98A.135728	Apr 21, 2020	$3.58 +105.75% Unrealistic Excluded from avg	$1.74	X	0.00%	1
JS Pro	Nov 11, 2019	$1.76 -12.44%	$2.01	X	87.56%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALNA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ALLENA PHARMACEUTICALS INC.

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newto...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by